Injectable simvastatin in periodontal defects and alveolar ridges: Pilot studies

Melissa S. Morris, Yeonju Lee, Mark T. Lavin, Peter J Giannini, Marian J. Schmid, David B. Marx, Richard A Reinhardt

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background: Topical injection of simvastatin in methylcellulose gel was shown to stimulate bone growth and inflammation over mouse calvaria and in rat mandible models. The purpose of these pilot studies was to evaluate the potential of locally injected simvastatin in human-sized periodontal defects. Methods: Chronic periodontal defects were created bilaterally in seven 1-year-old beagle dogs: 3-walled intrabony defects distal of the mandibular second premolar and mesial of the fourth premolar and Class II furcation defects at the buccal furcation of the mandibular first molars. The edentulous space distal to the mandibular canine was left undisturbed. After 16 weeks of healing, defect sites were treated with scaling and root planing, andmandible sides were randomly selected to receive three weekly injections of 0.5 mg simvastatin in 30 ml methylcellulose gel and contralateral gel alone (n = 3) or 2.0 mg simvastatin/methylcellulose gel and contralateral gel alone (n = 4). Two months following drug application, block sections, including teeth and surrounding tissues, and submandibular lymph nodes were obtained for histomorphometric analysis. Results: Two trends were noted in this pilot study: buccal edentulous ridge thickness was 29% greater with simvastatin, 0.5 mg, compared to gel alone (P = 0.0845), and the simvastatin groups had bone-height loss in interproximal intrabony and furcation defects, but the length of new cementum in the interproximal intrabony defects was greater with simvastatin, 0.5 mg (0.35 ± 0.14 mm), compared to gel alone (0.06 ± 0.15 mm; P = 0.069). No new cementum was found in furcations. Conclusions: Multiple injections of simvastatin are not appropriate for the treatment of intrabony or furcation defects. However, thisapproach showspotential toaugment bone thickness in closed alveolar environments.

Original languageEnglish (US)
Pages (from-to)1465-1473
Number of pages9
JournalJournal of periodontology
Volume79
Issue number8
DOIs
StatePublished - Aug 1 2008

Fingerprint

Alveolar Process
Simvastatin
Gels
Furcation Defects
Injections
Methylcellulose
Dental Cementum
Cheek
Bicuspid
Root Planing
Bone and Bones
Osteitis
Bone Development
Mandible
Skull
Canidae
Tooth
Lymph Nodes
Dogs

Keywords

  • Bone regeneration
  • Cementum
  • Drug delivery
  • Histology
  • Wound healing

ASJC Scopus subject areas

  • Periodontics

Cite this

Injectable simvastatin in periodontal defects and alveolar ridges : Pilot studies. / Morris, Melissa S.; Lee, Yeonju; Lavin, Mark T.; Giannini, Peter J; Schmid, Marian J.; Marx, David B.; Reinhardt, Richard A.

In: Journal of periodontology, Vol. 79, No. 8, 01.08.2008, p. 1465-1473.

Research output: Contribution to journalArticle

Morris, Melissa S. ; Lee, Yeonju ; Lavin, Mark T. ; Giannini, Peter J ; Schmid, Marian J. ; Marx, David B. ; Reinhardt, Richard A. / Injectable simvastatin in periodontal defects and alveolar ridges : Pilot studies. In: Journal of periodontology. 2008 ; Vol. 79, No. 8. pp. 1465-1473.
@article{8e22f4c0b2134c4f88a83ae293853540,
title = "Injectable simvastatin in periodontal defects and alveolar ridges: Pilot studies",
abstract = "Background: Topical injection of simvastatin in methylcellulose gel was shown to stimulate bone growth and inflammation over mouse calvaria and in rat mandible models. The purpose of these pilot studies was to evaluate the potential of locally injected simvastatin in human-sized periodontal defects. Methods: Chronic periodontal defects were created bilaterally in seven 1-year-old beagle dogs: 3-walled intrabony defects distal of the mandibular second premolar and mesial of the fourth premolar and Class II furcation defects at the buccal furcation of the mandibular first molars. The edentulous space distal to the mandibular canine was left undisturbed. After 16 weeks of healing, defect sites were treated with scaling and root planing, andmandible sides were randomly selected to receive three weekly injections of 0.5 mg simvastatin in 30 ml methylcellulose gel and contralateral gel alone (n = 3) or 2.0 mg simvastatin/methylcellulose gel and contralateral gel alone (n = 4). Two months following drug application, block sections, including teeth and surrounding tissues, and submandibular lymph nodes were obtained for histomorphometric analysis. Results: Two trends were noted in this pilot study: buccal edentulous ridge thickness was 29{\%} greater with simvastatin, 0.5 mg, compared to gel alone (P = 0.0845), and the simvastatin groups had bone-height loss in interproximal intrabony and furcation defects, but the length of new cementum in the interproximal intrabony defects was greater with simvastatin, 0.5 mg (0.35 ± 0.14 mm), compared to gel alone (0.06 ± 0.15 mm; P = 0.069). No new cementum was found in furcations. Conclusions: Multiple injections of simvastatin are not appropriate for the treatment of intrabony or furcation defects. However, thisapproach showspotential toaugment bone thickness in closed alveolar environments.",
keywords = "Bone regeneration, Cementum, Drug delivery, Histology, Wound healing",
author = "Morris, {Melissa S.} and Yeonju Lee and Lavin, {Mark T.} and Giannini, {Peter J} and Schmid, {Marian J.} and Marx, {David B.} and Reinhardt, {Richard A}",
year = "2008",
month = "8",
day = "1",
doi = "10.1902/jop.2008.070659",
language = "English (US)",
volume = "79",
pages = "1465--1473",
journal = "Journal of Periodontology",
issn = "0022-3492",
publisher = "American Academy of Periodontology",
number = "8",

}

TY - JOUR

T1 - Injectable simvastatin in periodontal defects and alveolar ridges

T2 - Pilot studies

AU - Morris, Melissa S.

AU - Lee, Yeonju

AU - Lavin, Mark T.

AU - Giannini, Peter J

AU - Schmid, Marian J.

AU - Marx, David B.

AU - Reinhardt, Richard A

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Background: Topical injection of simvastatin in methylcellulose gel was shown to stimulate bone growth and inflammation over mouse calvaria and in rat mandible models. The purpose of these pilot studies was to evaluate the potential of locally injected simvastatin in human-sized periodontal defects. Methods: Chronic periodontal defects were created bilaterally in seven 1-year-old beagle dogs: 3-walled intrabony defects distal of the mandibular second premolar and mesial of the fourth premolar and Class II furcation defects at the buccal furcation of the mandibular first molars. The edentulous space distal to the mandibular canine was left undisturbed. After 16 weeks of healing, defect sites were treated with scaling and root planing, andmandible sides were randomly selected to receive three weekly injections of 0.5 mg simvastatin in 30 ml methylcellulose gel and contralateral gel alone (n = 3) or 2.0 mg simvastatin/methylcellulose gel and contralateral gel alone (n = 4). Two months following drug application, block sections, including teeth and surrounding tissues, and submandibular lymph nodes were obtained for histomorphometric analysis. Results: Two trends were noted in this pilot study: buccal edentulous ridge thickness was 29% greater with simvastatin, 0.5 mg, compared to gel alone (P = 0.0845), and the simvastatin groups had bone-height loss in interproximal intrabony and furcation defects, but the length of new cementum in the interproximal intrabony defects was greater with simvastatin, 0.5 mg (0.35 ± 0.14 mm), compared to gel alone (0.06 ± 0.15 mm; P = 0.069). No new cementum was found in furcations. Conclusions: Multiple injections of simvastatin are not appropriate for the treatment of intrabony or furcation defects. However, thisapproach showspotential toaugment bone thickness in closed alveolar environments.

AB - Background: Topical injection of simvastatin in methylcellulose gel was shown to stimulate bone growth and inflammation over mouse calvaria and in rat mandible models. The purpose of these pilot studies was to evaluate the potential of locally injected simvastatin in human-sized periodontal defects. Methods: Chronic periodontal defects were created bilaterally in seven 1-year-old beagle dogs: 3-walled intrabony defects distal of the mandibular second premolar and mesial of the fourth premolar and Class II furcation defects at the buccal furcation of the mandibular first molars. The edentulous space distal to the mandibular canine was left undisturbed. After 16 weeks of healing, defect sites were treated with scaling and root planing, andmandible sides were randomly selected to receive three weekly injections of 0.5 mg simvastatin in 30 ml methylcellulose gel and contralateral gel alone (n = 3) or 2.0 mg simvastatin/methylcellulose gel and contralateral gel alone (n = 4). Two months following drug application, block sections, including teeth and surrounding tissues, and submandibular lymph nodes were obtained for histomorphometric analysis. Results: Two trends were noted in this pilot study: buccal edentulous ridge thickness was 29% greater with simvastatin, 0.5 mg, compared to gel alone (P = 0.0845), and the simvastatin groups had bone-height loss in interproximal intrabony and furcation defects, but the length of new cementum in the interproximal intrabony defects was greater with simvastatin, 0.5 mg (0.35 ± 0.14 mm), compared to gel alone (0.06 ± 0.15 mm; P = 0.069). No new cementum was found in furcations. Conclusions: Multiple injections of simvastatin are not appropriate for the treatment of intrabony or furcation defects. However, thisapproach showspotential toaugment bone thickness in closed alveolar environments.

KW - Bone regeneration

KW - Cementum

KW - Drug delivery

KW - Histology

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=49149110227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49149110227&partnerID=8YFLogxK

U2 - 10.1902/jop.2008.070659

DO - 10.1902/jop.2008.070659

M3 - Article

C2 - 18672997

AN - SCOPUS:49149110227

VL - 79

SP - 1465

EP - 1473

JO - Journal of Periodontology

JF - Journal of Periodontology

SN - 0022-3492

IS - 8

ER -